Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Grapefruit USA, Inc. (GPFT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0100+0.0020 (+25.00%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0080
Open0.0079
BidN/A x N/A
AskN/A x N/A
Day's Range0.0079 - 0.0100
52 Week Range0.0060 - 0.0450
Volume521,455
Avg. Volume374,196
Market Cap6.003M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for GPFT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GRAPEFRUIT USA INC
    Analyst Report: Zimmer Biomet Holdings IncBased in Warsaw, Indiana, Zimmer Biomet is the nation's largest pure-play maker of orthopedic devices. The company designs, develops and manufactures reconstructive orthopedic implants, including joint, dental and spinal implants; sports injury repair and trauma products; and related orthopedic surgical products. Its primary customers include musculoskeletal surgeons, neurosurgeons, hospitals, distributors, and, in their capacity as agents, healthcare purchasing organizations or buying groups. Zimmer has approximately 20,000 employees. ZBH shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement